StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.88−0.08 (-8.24%)

Close on Nov 16, 2026Market cap $13.93MP/E –Yield –

Allarity Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Allarity Therapeutics

Allarity Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Allarity Therapeutics figures

See a number that looks wrong?